To kick-off European Biotech Week, EuropaBio organised a multi-stakeholder conference, which enabled speakers from industry, public authorities, patient organisations, academics and healthcare professionals to address a number of key issues concerning personalised medicine. Discussions focused on the importance of timely access to personalised medicine for patients as well as the need to speed up clinical development of new molecules in Europe.